West Oak Capital’s Avanos Medical AVNS Stock Holding History

West Oak Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-68	Closed	-$2.59K	–	348
2017 Q1	$2.59K	Buy	+68	New	+$2.65K	﹤0.01%	345
2015 Q3	–	Sell	-5	Closed	-$203	–	299
2015 Q2	$203	Hold	5	–	–	﹤0.01%	302
2015 Q1	$246	Hold	5	–	–	﹤0.01%	301
2014 Q4	$227	Buy	+5	New	+$196	﹤0.01%	311

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

West Oak Capital's AVNS Position: Q2 2017 in Review

West Oak Capital sold out of Avanos Medical (AVNS) in Q2 2017, closing a stake of 68 shares — an estimated $2.59K sold.

West Oak Capital first reported a position in AVNS in Q4 2014 and held it in 4 quarters. The position peaked at $2.59K in Q1 2017. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

West Oak Capital reported no remaining Avanos Medical position as of Q2 2017 after selling out during the quarter.
West Oak Capital sold 68 Avanos Medical shares in Q2 2017, an estimated $2.59K.
West Oak Capital first reported a position in Avanos Medical in Q4 2014 and held it in 4 quarters.
West Oak Capital's Avanos Medical position peaked at $2.59K in Q1 2017.
328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on West Oak Capital's 13F filing for Q2 2017, filed 6 Jul 2017.